Best Topical Treatment for Pressure Ulcers
For patients with existing pressure ulcers, use hydrocolloid or foam dressings as your primary topical treatment, not traditional ointments. 1
Treatment Approach Based on Clinical Situation
For Active Pressure Ulcers (Treatment)
The American College of Physicians 2015 guidelines provide clear direction that dressings, not ointments, are the evidence-based topical approach 1:
- Hydrocolloid dressings are superior to gauze dressings for reducing wound size (weak recommendation, low-quality evidence)
- Foam dressings (hydrocellular or polyurethane) perform similarly to hydrocolloid dressings for complete wound healing
- Both are recommended over traditional topical ointments or creams
Silicone foam dressings specifically show the most promising results in recent evidence, with one 2025 retrospective analysis finding multilayer silicone foam dressing to be the most effective topical therapy 2. Earlier research supports this, showing silicone dressings may reduce pressure ulcer incidence (RR 0.25,95% CI 0.16 to 0.41) 3.
For Prevention (At-Risk Patients)
Apply silicone foam dressings prophylactically to high-risk pressure points (sacrum, heels, hips) in immobile patients 4, 3. The evidence suggests these may reduce pressure ulcer development, though certainty is low.
What NOT to Use
Avoid these topical agents based on evidence:
- Rifamycin and povidone-iodine solutions - associated with worsening PU condition 2
- DMSO cream - may increase pressure ulcer incidence (RR 1.99) 3
- Dextranomer paste - inferior to other dressings 1
Specific Ointments: Limited Evidence
If you specifically need an ointment rather than a dressing:
- Fatty acid-containing preparations show some benefit over control compounds (RR 0.42,95% CI 0.22 to 0.80), though evidence is low-quality 3
- Moist Exposed Burn Ointment (MEBO) showed effectiveness in one 2017 Chinese trial with 50% complete healing versus 16.7% with placebo 5, but this is a single study with limited generalizability
- Aloe vera-derived micellar emulsion showed promise in a 2026 case report for stage IV ulcers 6, but case reports provide very weak evidence
Critical Caveats
The evidence quality is universally low to very low across all interventions 1, 4. The ACP guidelines note that most recommendations are weak, and the relationship between wound size reduction and complete healing remains poorly defined 1.
Common pitfall: Clinicians often reach for antibiotic ointments or antiseptic solutions reflexively. The evidence shows these are either ineffective or potentially harmful. Stick with modern dressings that maintain moist wound healing environments.
Duration matters: Patients hospitalized >30 days showed higher treatment success rates, indicating these therapies require adequate time to work 2.
Adjunctive Measures (Beyond Topical Treatment)
While you asked about topical agents, the guidelines emphasize these must be combined with:
- Protein or amino acid supplementation to reduce wound size 1
- Electrical stimulation as adjunctive therapy to accelerate healing (moderate-quality evidence) 1
- Pressure redistribution (the most critical intervention)
Bottom line: Modern foam or hydrocolloid dressings outperform traditional ointments for pressure ulcer management. If institutional protocols or patient preference demands an ointment, fatty acid preparations have the best (though still limited) evidence.